Form D · Other Technology
Turquoise Health Co.
San Diego, CA · CIK 0001869121
Offering snapshot reported Jan 25, 2024 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2024 | Initial | $29,999,994 | No comparison | 10 | SEC filing |
| May 11, 2022 | Initial | $20,000,000 | No comparison | 11 | SEC filing |
| Jun 24, 2021 | Initial | $5,178,452 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503488
Source: Form D, filed Jan 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Bremner | Director |
| Adam Geitgey | Director, Executive |
| Christopher Reid Severn | Director, Executive |
| Julie Yoo | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
421 Broadway #5108
San Diego, CA, 92101
San Diego, CA, 92101